Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-004597
Filing Date
2025-04-08
Accepted
2025-04-08 16:10:19
Documents
19
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A vstm-20250522xdef14a.htm   iXBRL DEF 14A 1172358
2 GRAPHIC vstm-20250522xdef14a006.jpg GRAPHIC 39685
3 GRAPHIC vstm-20250522xdef14a007.jpg GRAPHIC 54348
4 GRAPHIC vstm-20250522xdef14a009.jpg GRAPHIC 801
  Complete submission text file 0001558370-25-004597.txt   3011293

Data Files

Seq Description Document Type Size
5 EX-101.SCH vstm-20250522.xsd EX-101.SCH 6073
6 EX-101.DEF vstm-20250522_def.xml EX-101.DEF 5401
7 EX-101.LAB vstm-20250522_lab.xml EX-101.LAB 20759
8 EX-101.PRE vstm-20250522_pre.xml EX-101.PRE 11763
21 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20250522xdef14a_htm.xml XML 660803
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35403 | Film No.: 25822044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)